{"disease":{"id":"progressive-keratoconus","name":"progressive keratoconus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03442751","title":"Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Glaukos Corporation","has_results":true},{"nct_id":"NCT04427956","title":"Corneal Crosslinking Treatment Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04504578","title":"Efficacy and Safety ofCACXL in the Treatment of Keratoconus With Thin Corneas","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}